Business
Roadman Appoints Dr. James Hudson, Ph.D to Scientific Advisory Board
(via TheNewswire) March 11, 2020 - TheNewswire - VANCOUVER, British Columbia - R...
About this update from Futuregen Industries Corp.
[{"type":"text","content":"Roadman Appoints Dr. James Hudson, Ph.D to Scientific Advisory Board(via TheNewswire)\n \n \nMarch 11, 2020 - TheNewswire - VANCOUVER, British Columbia - Roadman Investments Corp. (TSXV:LITT)(FWB:1QD)(OTC:RMANF) (\"Roadman Investments\" or the \"Company\") is pleased to announce that, in connection with Roadman's recent acquisition of CLOV Biopharma Corp. (\"CBP\"), Dr. James Hudson, Ph.D has been appointed to the Company's Scientific Advisory Board effective immediately. \n\n \n \nLuke Montaine, CEO of Roadman Investments commented, \"We are delighted to have Dr. Hudson join our Advisory Board as his notable expertise in virology and pathology will be critical in the continued advancement of CLOV Biopharma Corp.'s mandate.\"\n\n \n \nDr. James Hudson\n\n \n \nDr. James B. Hudson, Ph.D, Professor Emeritus Department of Pathology & Laboratory Medicine at the University of British Columbia, has completed various publications including \"The activity of cedar leaf oil vapor against respiratory viruses\" in the Journal of Applied Pharmaceutical Science and \"The antimicrobial properties of cedar leaf (Thuja plicata) oil\" in the International Journal of Respiratory Public Health. Dr. Hudson will assist CBP and Roadman with further studies to research the effectiveness of cedar leaf oil vapour (\"CLOV\") on the Coronavirus. \n\n \n \nDr. Hudson is considered to be one of the foremost virologists in Canada. His qualifications include a BSc (chemistry/physiology), an MSc (biochemistry), a PhD (molecular biology) a post-doctoral fellowship in molecular virology. In addition, he has received visiting professorships in University of Warwick (UK), 1976-1977, and University of Western Australia (Perth WA) in 1990 and 1992. \n\n \n \nOf relevance to Coronavirus, Dr. Hudson conducted a study involving seven (7) respiratory viruses that were tested for infectivity following exposure of dried virus films to certified cedar leaf oil vapor for various periods of time. All were susceptible, although the membrane containing viruses, like CoV, were more vulnerable and were readily killed by short exposures without detrimental effects against the human cells. Previous studies by Dr. James Hudson, Ph.D have shown that most of the human respiratory viruses tested so far have been found vulnerable to cedar leaf oil and cedar leaf oil vapour. It is e...